Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-08 Sale |
2023-11-13 2:49 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
51,790 | $19 | $984,010 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-08 Equity Swap |
2023-11-13 2:49 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
28,349 | $19 | 0 (Direct) |
View |
| 2023-09-14 Tax Withholding |
2023-09-18 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $11.57 | 80,139 (Direct) |
View |
| 2023-06-14 Tax Withholding |
2023-06-16 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $12.04 | 81,385 (Direct) |
View |
| 2023-03-14 Tax Withholding |
2023-03-16 4:07 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
1,246 | $15.79 | 82,631 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 8:25 pm |
N/A 2033-02-15 |
Ocean Biomedical Inc. | OCEA | Berrey M Michelle Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 4:03 pm |
N/A 2033-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
38,700 | $0 | 107,877 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO |
765 | $12.37 | 69,177 (Direct) |
View |
| 2022-12-14 Tax Withholding |
2022-12-16 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
1,246 | $14.94 | 69,942 (Direct) |
View |
| 2022-09-14 Tax Withholding |
2022-09-16 4:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
1,246 | $17.14 | 71,188 (Direct) |
View |
| 2022-06-14 Tax Withholding |
2022-06-16 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
4,984 | $12.1 | 72,434 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 4:13 pm |
N/A 2032-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
27,900 | $0 | 95,018 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-15 7:01 pm |
N/A 2031-06-14 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO |
160,118 | $0 | 160,118 (Direct) |
View |